Bedaquiline, Pretomanid and Linezolid

Abbreviation
BPaL
Disease(s)
Tuberculosis
Background
.pdf
Patent oppositions filed in
India

BPaL (Bedaquiline, Pretomanid and Linezolid) is a three drug regimen approved in the treatment of XDR-TB (Extensively drug resistant) and MDR-TB (Multi Drug Resistant). This drug regime can reduce the present TB treatment duration to only 6 months.

This drug is missing the following documents, can you help us by contributing something?

Patent Information

Information of patent applications filed at local or international levels, that are contributed by the users of PODB as being relevant to this medicine

Please note that PODB does not provide and guarantee the comprehensive patent landscape in all countries.

*For more knowledge of patent search, please refer to the tutorial Step 2: Patent Search & Analysis
*For more information of the patent landscape on medicines, please also refer to WHO patent landscape reports, UNITAID patent landscape reports, Medicines Patent Pool Patent Status Database

Patent Applications

The table includes information of patent applications as filed in different countries, that are contributed by PODB users as being seen as relevant to this medicine.

CountryFiling datePriority dateApplicantNational numberInternational numberStatusPatent typeMore info
India16-04-2018The Global Alliance For TB Drug Development Inc201817014361WO2017/066053Under ExaminationCompositionsView/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top

Oppositions

Information related to relevant oppositions from around the world.

Patent Oppositions

The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.

Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.

CountryDateWho FiledOpposition typeOpposition statusPatent typeRelated patent applicationMore info
India24-07-2020Eldred Tellis and Ganesh AcharyaPre-GrantUnder ExaminationCompositions201817014361View/Comment
India28-07-2020Delhi Network of Positive People (DNP+)Pre-GrantUnder ExaminationCompositions201817014361View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top